[20211020]LSB10584_2019冠状病毒疾病疫苗潜在伤害赔偿计划.pdf

CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Compensation Programs for Potential COVID-19 Vaccine Injuries Updated October 20, 2021 More than 200 million Americans have received one or more doses of a Coronavirus Disease 2019 (COVID-19) vaccine, along with billions of people worldwide. The Food and Drug Administrations (FDAs) emergency use authorizations for the Pfizer-BioNTech, Moderna, and Johnson & Johnson COVID-19 vaccines were based on months-long clinical trials (including safety monitoring) of each vaccine, involving tens of thousands of participants. These trials did not identify any safety concerns that would preclude such authorization. (The Pfizer-BioNTech COVID-19 vaccine subsequently received full approval from FDA.) Post-authorization, the COVID-19 vaccines have been subject to safety monitoring requirements by FDA and the Centers for Disease Control and Prevention (CDC) to detect long-term or rare adverse health events. (For more information, see this CRS report.) The most common side effects of COVID-19 vaccines are mildsuch as local pain around the injection side, tiredness, or feverand usually resolve within a few